High-Throughput Screening Assays
"High-Throughput Screening Assays" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Rapid methods of measuring the effects of an agent in a biological or chemical assay. The assay usually involves some form of automation or a way to conduct multiple assays at the same time using sample arrays.
| Descriptor ID |
D057166
|
| MeSH Number(s) |
E05.916.680
|
| Concept/Terms |
High-Throughput Screening Assays- High-Throughput Screening Assays
- Assay, High-Throughput Screening
- High Throughput Screening Assays
- High-Throughput Screening Assay
- Screening Assay, High-Throughput
- Screening Assays, High-Throughput
High-Throughput Screening Methods- High-Throughput Screening Methods
- High Throughput Screening Methods
- High-Throughput Screening Method
- Methods, High-Throughput Screening
- Screening Method, High-Throughput
- Screening Methods, High-Throughput
High-Throughput Biological Assays- High-Throughput Biological Assays
- Assay, High-Throughput Biological
- Assays, High-Throughput Biological
- Biological Assay, High-Throughput
- Biological Assays, High-Throughput
- High Throughput Biological Assays
- High-Throughput Biological Assay
High-Throughput Chemical Assays- High-Throughput Chemical Assays
- Assay, High-Throughput Chemical
- Assays, High-Throughput Chemical
- Chemical Assay, High-Throughput
- Chemical Assays, High-Throughput
- High Throughput Chemical Assays
- High-Throughput Chemical Assay
|
Below are MeSH descriptors whose meaning is more general than "High-Throughput Screening Assays".
Below are MeSH descriptors whose meaning is more specific than "High-Throughput Screening Assays".
This graph shows the total number of publications written about "High-Throughput Screening Assays" by people in this website by year, and whether "High-Throughput Screening Assays" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2009 | 3 | 0 | 3 |
| 2010 | 5 | 3 | 8 |
| 2011 | 6 | 5 | 11 |
| 2012 | 7 | 4 | 11 |
| 2013 | 4 | 12 | 16 |
| 2014 | 5 | 8 | 13 |
| 2015 | 6 | 10 | 16 |
| 2016 | 2 | 7 | 9 |
| 2017 | 6 | 2 | 8 |
| 2018 | 4 | 6 | 10 |
| 2019 | 3 | 2 | 5 |
| 2020 | 3 | 8 | 11 |
| 2021 | 3 | 4 | 7 |
| 2022 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "High-Throughput Screening Assays" by people in Profiles.
-
Xanthine derivatives inhibit FTO in an L-ascorbic acid-dependent manner. Chem Commun (Camb). 2023 Sep 07; 59(72):10809-10812.
-
Automating the High-Throughput Screening of Protein-Based Optical Indicators and Actuators. Biochemistry. 2023 01 17; 62(2):169-177.
-
Identification of the Benzoimidazole Compound as a Selective FLT3 Inhibitor by Cell-Based High-Throughput Screening of a Diversity Library. J Med Chem. 2022 02 24; 65(4):3597-3605.
-
Assessing kinetics and recruitment of DNA repair factors using high content screens. Cell Rep. 2021 12 28; 37(13):110176.
-
Characterization of a high throughput human stem cell cardiomyocyte assay to predict drug-induced changes in clinical electrocardiogram parameters. Eur J Pharmacol. 2021 Dec 05; 912:174584.
-
Rational Combination of CRM1 Inhibitor Selinexor and Olaparib Shows Synergy in Ovarian Cancer Cell Lines and Mouse Models. Mol Cancer Ther. 2021 12; 20(12):2352-2361.
-
A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma. J Clin Endocrinol Metab. 2021 09 27; 106(10):2962-2978.
-
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition. Cell Rep. 2021 10 05; 37(1):109784.
-
Discovery and characterization of bromodomain 2-specific inhibitors of BRDT. Proc Natl Acad Sci U S A. 2021 03 02; 118(9).
-
Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma. Cancer Sci. 2021 Mar; 112(3):1225-1234.